pembrolizumab

pembrolizumab

pembrolizumab

Min.Order / FOB Price:Get Latest Price

0

Negotiable

  • Min.Order :0
  • Purity: 95%

Keywords

Anti-PD-1 monoclonal antibody - Merck Humanised monoclonal IgG4 antibody against PD-1 - Merck

Quick Details

  • Appearance:
  • Application:For research use only.
  • PackAge:
  • ProductionCapacity:
  • Storage:
  • Transportation:

Superiority:

We provide customized and high-quality pembrolizumab product for your project.

Details:

Pembrolizumab (formerly MK-3475 and lambrolizumab, trade name Keytruda) is a humanized antibody used in cancer immunotherapy. It targets the programmed cell death 1 (PD-1) receptor. The drug was initially used in treating metastatic melanoma.

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View